Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation

Antimicrobial Agents and Chemotherapy

Volumn 38, Issue 3, 1994, Pages 576-579

  Broun, E R ^a   Wheat, J L ^a   Kneebone, P H ^a   Sundblad, K ^a   Hromas, R A ^a   Tricot, G ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN; ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CEFOPERAZONE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; IFOSFAMIDE; IMIPENEM; NORFLOXACIN; PENICILLIN G; SULBACTAM; SULPERAZON; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG MEGADOSE; FEMALE; FEVER; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; OVARY CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; STREPTOCOCCUS INFECTION;

EID: 0028273358     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.38.3.576     Document Type: Article

References (0)